MAPK3 and hepatocellular carcinoma: Extracellular signal-regulated kinases 1 and 2 (ERK1/2), encoded by MAPK3 and MAPK1, are key components of the MAPK pathway, which is aberrantly activated in over 75% of HCC cases [15].